Cargando…
S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428355/ http://dx.doi.org/10.1097/01.HS9.0000967748.33927.a8 |
| _version_ | 1785090448892624896 |
|---|---|
| author | Jungius, Sarah Mattei, Sara Stivala, Simona Szybinski, Jakub Vokalova, Lenka Rovó, Alicia Angelillo-Scherrer, Anne Dirnhofer, Stefan Meyer, Sara |
| author_facet | Jungius, Sarah Mattei, Sara Stivala, Simona Szybinski, Jakub Vokalova, Lenka Rovó, Alicia Angelillo-Scherrer, Anne Dirnhofer, Stefan Meyer, Sara |
| author_sort | Jungius, Sarah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428355 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283552023-08-17 S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS Jungius, Sarah Mattei, Sara Stivala, Simona Szybinski, Jakub Vokalova, Lenka Rovó, Alicia Angelillo-Scherrer, Anne Dirnhofer, Stefan Meyer, Sara Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428355/ http://dx.doi.org/10.1097/01.HS9.0000967748.33927.a8 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Jungius, Sarah Mattei, Sara Stivala, Simona Szybinski, Jakub Vokalova, Lenka Rovó, Alicia Angelillo-Scherrer, Anne Dirnhofer, Stefan Meyer, Sara S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS |
| title | S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_full | S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_fullStr | S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_full_unstemmed | S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_short | S209: TARGETING THE SRC HOMOLOGY 2 DOMAIN-CONTAINING PHOSPHATASE SHP2 ENHANCES THE THERAPEUTIC EFFICACY OF JAK INHIBITION IN MYELOPROLIFERATIVE NEOPLASMS |
| title_sort | s209: targeting the src homology 2 domain-containing phosphatase shp2 enhances the therapeutic efficacy of jak inhibition in myeloproliferative neoplasms |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428355/ http://dx.doi.org/10.1097/01.HS9.0000967748.33927.a8 |
| work_keys_str_mv | AT jungiussarah s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms AT matteisara s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms AT stivalasimona s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms AT szybinskijakub s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms AT vokalovalenka s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms AT rovoalicia s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms AT angelilloscherreranne s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms AT dirnhoferstefan s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms AT meyersara s209targetingthesrchomology2domaincontainingphosphataseshp2enhancesthetherapeuticefficacyofjakinhibitioninmyeloproliferativeneoplasms |